Challenges to vaccine safety

Primary Care - Clinics in Office Practice

Volumn 28, Issue 4, 2001, Pages 853-868

  Marshall, Gary S ^a   Gellin, Bruce G ^b  

^a University of Louisville School of Medicine   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; MEASLES MUMPS RUBELLA VACCINE; ORAL POLIOMYELITIS VACCINE; THIOMERSAL;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AUTISM; CLINICAL TRIAL; DIABETES MELLITUS; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG INFORMATION; DRUG SAFETY; FINLAND; HEALTH CARE DELIVERY; HUMAN; IMMUNE SYSTEM; INFECTION PREVENTION; INTERNET; MULTIPLE SCLEROSIS; NEUROTOXICITY; PRIORITY JOURNAL; REVIEW; SUDDEN INFANT DEATH SYNDROME; UNITED KINGDOM; VACCINATION;

EID: 0035185760     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0095-4543(05)70044-0     Document Type: Article

References (120)

1. Absence of detectable measles virus genome sequence in inflammatory bowel disease tissues and peripheral blood lymphocytes
2. Absence of measles-virus genome in inflammatory bowel disease
3. The last smallpox epidemic in Boston and the vaccination controversy 1901-1903
4. Hepatitis B vaccination and the risk of multiple sclerosis
5. The pathogenesis of insulin-dependent diabetes mellitus
6. An assessment of thimerosal use in childhood vaccines
7. Risky business: Challenges in vaccine risk communication
8. Possible temporal association between diphtheriatetanus toxoid-pertussis vaccination and sudden infant death syndrome
9. Edward Jenner's inquiry: A bicentary analysis
10. Analysis of oral polio vaccine CHAT stocks
11. Polio vaccine samples not linked to AIDS
12. Availability of hepatitis B vaccine that does not contain thimerosal as a preservative
13. Hepatitis B virus: A comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: Recommendations of the Immunization Practices Advisory Committee (ACIP)
14. Hepatitis prevention through universal childhood vaccination: Recommendations of the Immunization Practices Advisory Committee (ACIP)
15. Impact of the 1999 AAP/USPHS joint statement on thimerosal in vaccines on infant hepatitis B vaccination practices
16. Impact of vaccines universally recommended for children-United States 1990-1998
17. National state and urban area vaccination coverage levels among children aged 19-35 months. United States 1999
18. Summary of the joint statement on thimerosal in vaccines
19. Pertussis vaccination: Use of acellular pertussis vaccines among infants and young children
20. Poliomyelitis prevention in the United States: Updated recommendations of the Advisory Committee on Immunization Practices (ACIP)
21. Recommended childhood immunization schedule. United States 2001
22. Ten great public health achievements - United States 1990-1999
23. Thimerosal in vaccines: A joint statement of the American Academy of Pediatrics and the Public Health Service
24. Measles virus RNA is not detected in inflammatory bowel disease using hybrid capture and reverse transcription followed by the polymerase chain reaction
25. Challenges and controversies in immunization safety
26. Vaccine adverse events: Causal or coincidental?
27. Vaccine safety: Current and future challenges
28. Safety of vaccines
29. The timing of pediatric immunization and the risk of insulindependent diabetes mellitus
30. The timing of immunization affects the development of diabetes in rodents
31. The diabetes epidemic and the hepatitis B vaccines
32. Vaccinations and the risk of relapse in multiple sclerosis
33. Risk comparison and risk communication: Issues and problems comparing health and environmental risks
34. Time trends in autism and in MMR immunization coverage in California
35. Effects of prenatal and postnatal methylmercury exposure from fish consumption on neurodevelopmental outcomes at 66 months of age in the Seychelles Child Development Study
36. Measles-mumps-rubella and other measles containing vaccines do not increase the risk for inflammatory bowel disease: A casecontrol study from the vaccine safety datalink project
37. Hepatitis B and Hib vaccines are not associated with increased risk of type 1 diabetes
38. The incidence of male childhood type 1 (insulin-dependent) diabetes mellitus is rising rapidly in the Netherlands
39. Perinatal measles infection and subsequent Crohn's disease
40. The complicated task of monitoring vaccine safety
41. Production and immunologic analysis of recombinant hepatitis B vaccine
42. Individual and community risks of measles and pertussis associated with personal exemptions to immunization
43. The screening and diagnosis of autistic spectrum disorders
44. The U.K. accelerated immunization program and sudden unexpected death in infancy: Case-control study
45. Is there an epidemic of autism?
46. The epidemiology of autism: A review
47. Association between hepatitis B vaccine and multiple sclerosis
48. Opposition to immunization: A pattern of deception
49. Molecular mimicry as a mechanism for virus-induced autoimmunity
50. Colonic CD8 and γδ T-cell infiltration with epithelial damage in children with autism
51. Do parents understand immunizations? A national telephone survey
52. The risk of vaccination: The importance of "negative" studies
53. Lack of association between early childhood immunizations and beta-cell autoimmunity
54. Postmodern medicine
55. Risk of sudden infant death syndrome after immunization with the diphtheria-tetanus-pertussis vaccine
56. Absence of measles viral genomic sequence in intestinal tissues from Crohn's disease by nested polymerase chain reaction
57. AIDS as a zoonosis: Scientific and public health implications
58. Hepatitis B vaccine and central nervous system demyelinating diseases
59. Limiting infant exposure to thimerosal in vaccines and other sources of mercury
60. Conference Writing Panel: Measles-Mumps-Rubella vaccine and autistic spectrum disorder: Report from the new challenges in childhood immunizations conference convened in Oak Brook Illinois June 12-13 2000
61. Regulation and testing of vaccines
62. New data challenge OPV theory of AIDS origin
63. Adverse events following pertussis and rubella vaccines: Summary of a report of the Institute of Medicine
64. Immunohistochemical analysis of the distribution of measles related antigen in the intestinal mucosa in inflammatory bowel disease
65. Measles vaccination and inflammatory bowel disease
66. Absence of measles virus in Crohn's disease
67. Childhood immunizations and type 1 diabetes: Summary of an Institute for Vaccine Safety Workshop
68. No evidence that vaccines cause insulin dependent diabetes mellitus
69. Association between type 1 diabetes and Haemophilus influenzae type b vaccination: Birth cohort study
70. Mumps measles and rubella vaccine and the incidence of autism recorded by general practitioners: A time trend analysis
71. Death helped write the biologics law
72. Timing the ancestor of the HIV-1 pandemic strains
73. Autism: Recent molecular genetic advances
74. Review of the toxicity of ethylmercury including its presence as a preservative in biological and pharmaceutical products
75. A shadow falls on hepatitis B vaccination effort
76. Paramyxovirus infections in childhood and subsequent inflammatory bowel disease
77. Intussusception among infants given an oral rotavirus vaccine
78. The Cutter incident: Poliomyelitis following formaldehyde-inactivated poliovirus vaccination in the United States during the spring of 1955
79. Autism and vaccines: A new look at an old story
80. Neonatal deaths after hepatitis B vaccine: The vaccine adverse event reporting system 1991-1998
81. No evidence for measles mumps and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study
82. Blood mercury levels in infants receiving thimerosal containing vaccines
83. CHAT oral polio vaccine was not the source of human immunodeficiency virus type 1 group M for humans
84. Molecular analysis of oral polio vaccine samples
85. Vaccine safety: Injecting a dose of common sense
86. Phylogeny and the origin of HIV-1
87. Autism
88. The early origins of autism
89. School-based hepatitis B vaccination programme and adolescent multiple sclerosis
90. Reassessment of the association between Guillain-Barré syndrome and the receipt of swine influenza vaccine in 1976-1977: Results of a two-state study
91. Health consequences of religious and philosophical exemptions from immunization laws: Individual and societal risk of measles
92. Primary vaccination of infants with diphtheriatetanus-acellular pertussis-hepatitis B virus-inactivated polio virus and Haemophilus influenzae type b vaccines given as either separate or mixed injections
93. Iatrogenic exposure to mercury after hepatitis B vaccination in preterm infants
94. Public doubts about vaccination safety and resistance against vaccination
95. Changing concepts of sudden infant death syndrome: Implications for infant sleeping environment and sleep position
96. Autism and measles mumps and rubella vaccine: No epidemiological evidence for a causal association
97. Is measles vaccination a risk factor for inflammatory bowel disease?
98. Diphtheria-pertussis-tetanus (DPT) immunization: A potential cause of the sudden infant death syndrome (SIDS)
99. Increase in incidence of insulin-dependent diabetes mellitus among children in Finland
100. Immunologic Reactions
101. Ileal-lymphoid-nodular hyperplasia nonspecific colitis and pervasive developmental disorder in children
102. Evidence of persistent measles virus infection in Crohn's disease
103. Diphtheria-tetanus-pertussis immunization and sudden infant death syndrome
104. Association between measles infection and the occurrence of chronic inflammatory bowel disease
105. No increase in demyelinating diseases after hepatitis B vaccination